FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/06/2024
Back to search
Official data from USPTO
CELLAÏON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
06/06/2024
Trademark type
Word
Nice classes
5, 42
Filing date
06/16/2022
Registration date
03/05/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/05/2024
Last transaction
03/05/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
BE
Examiner
EINSTEIN, MATTHEW
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cellaïon, société anonyme
Representatives
Clifford D Hyra Fresh IP PLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells originating from human tissuefor medicalclinical or veterinary useliver derived cells and stem cells or liver progenitor cells; pharmaceutical preparations in the field of liver derived cells and stem cells or liver progenitor cells for the treatment of diseases that require cell therapy medicinal productsliver diseaseschronic biliary diseasescholestatic diseasesage-related diseasesbone and cartilage disorderspancreatic diseaseskidney diseasespulmonary diseasescardiovascular diseaseseye diseasesocular diseasesorgan injuryorgan failureblood coagulation disordersClarkson diseasediabetesskin diseasescancermetabolic diseasesinflammatory diseasesinflammationneurodegenerative diseasesfibrotic diseasesproliferative diseasesinfectious diseasesautoimmune diseasesdiseases with unwanted immune responsesepsissepsis induced diseasescellular senescence; surgical implants comprised of living tissue grown from stem cells or progenitor cells in the field of liver derived cells and stem cells or liver progenitor cells; transplants being living tissue in the form of liver derived cells and stem cells or liver progenitor cells; live organs and tissues for surgical purpose in the field of liver derived cells and stem cells or liver progenitor cells; surgical implants comprising living tissue grown from stem cells or progenitor cells in the field of liver derived cells and stem cells or liver progenitor cells; cell-based pharmaceutical preparations in the field of liver derived cells and stem cells or liver progenitor cells for the treatment of liver diseaseschronic biliary diseasescholestatic diseasesage-related diseasesbone and cartilage disorderspancreatic diseaseskidney diseasespulmonary diseasescardiovascular diseaseseye diseasesocular diseasesorgan injuryorgan failureblood coagulation disordersClarkson diseasediabetesskin diseasescancermetabolic diseasesinflammatory diseasesinflammationneurodegenerative diseasesfibrotic diseasesproliferative diseasesinfectious diseasesautoimmune diseasesdiseases with unwanted immune responsesepsissepsis induced diseasescellular senescence
Class 42
Biomedical research and development services in relation to the testing of biological samples to determine the presence and activity of stem cellsprogenitor cells and liver cellsin particularliver stem cells and liver progenitor cells
Publications
History of USPTO decisions and trademark events.
34 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/05/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/21/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/21/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/21/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/21/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/21/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/21/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/19/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/19/2023
PUBO
PUBLISHED FOR OPPOSITION
12/19/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/29/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/29/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/16/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/21/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2023
RFNT
REFUSAL PROCESSED BY IB
06/26/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/03/2023
RFRR
REFUSAL PROCESSED BY MPU
06/03/2023
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
05/23/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/06/2023
CNRT
NON-FINAL ACTION WRITTEN
04/05/2023
DOCK
ASSIGNED TO EXAMINER
03/29/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
03/19/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
12/01/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/19/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/16/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/11/2022
Continuous trademark protection
Get notified about every new filing that threatens CELLAÏON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.